Overview of Dofen

Dofen is a recognized brand name for a synthetic medicinal product containing the active ingredient Ibuprofen, which is globally classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID). Its core identity is that of a single-ingredient, systemic treatment developed to manage generalized physical discomfort.

Property	Description
Active Ingredient	Ibuprofen
Common Forms	Tablets, Capsules (Softgel), Suspension
Pharmacological Class	Non-Steroidal Anti-Inflammatory Drug (NSAID)
General Purpose	Analgesic, Antipyretic, Anti-inflammatory
Origin	Synthetic (Propionic acid derivative)

Chemical Identity and Pharmacological Classification

Dofen's core is the active substance, Ibuprofen, a propionic acid derivative that is commercially manufactured. Pharmacological studies confirm Ibuprofen's efficacy as a well-established agent. As an NSAID, Dofen provides relief by targeting biological pathways that mediate pain, distinguishing it from pure analgesics. The over-the-counter (OTC) status of Dofen in many regions reflects its extensive history of safe use and clinical recognition for symptomatic management.

Forms, Composition, and Systemic Use

Dofen is primarily designed for the Oral Route of administration, and is available in forms such as tablets, softgel capsules, and liquid suspensions. The softgel capsule is a distinctive feature often favored for its quick dissolution characteristics, which are clinically recognized to facilitate faster systemic absorption.

The composition centers on the Ibuprofen, combined with pharmaceutical base components and excipients suitable for the specific form. The oral route confirms the drug is intended to provide comprehensive action throughout the body. The variety of forms, such as the use of an aqueous vehicle in suspensions, makes the medication accessible for different needs.

General Purpose: Pain, Fever, and Inflammation Relief

The general purpose of Dofen is to serve as an analgesic, antipyretic, and anti-inflammatory agent, providing reliable symptomatic control against common types of discomfort. This triple therapeutic outcome is supported by extensive research into NSAIDs, confirming the medication's effectiveness in providing relief. A common, neutral use is providing temporary relief from muscular aches, where its anti-inflammatory properties are particularly beneficial.

Regulatory References

What side effects are possible with Dofen?

Possible Side Effects and Safety Information

Dofen, which belongs to the class of nonsteroidal anti-inflammatory drugs (NSAIDs), carries specific regulatory warnings concerning potential serious health risks. The officially documented safety profile requires careful consideration, particularly related to cardiovascular and gastrointestinal systems.

Classification	Common Adverse Reactions (CIOMS ge1/100 to <1/10)
Gastrointestinal	Abdominal pain, nausea, diarrhea, heartburn
Nervous System	Headache, dizziness, drowsiness
Dermatological	Rash

Serious and Clinically Significant Adverse Reactions

The most serious, clinically significant risks cited in regulatory documents include:

Cardiovascular Thrombotic Events: Dofen is associated with an increased risk of serious, and potentially fatal, cardiovascular thrombotic events, including myocardial infarction (heart attack) and stroke. The risk may increase with duration of use.
Gastrointestinal Risk: The drug carries a documented risk of serious gastrointestinal adverse events, such as bleeding, ulceration, and perforation of the stomach or intestines, which can occur at any time without warning symptoms.
Hepatotoxicity and Nephrotoxicity: Liver and kidney function impairment, including severe hepatotoxicity and acute renal failure, have been reported and necessitate monitoring.
Severe Skin Reactions: Rare but serious skin reactions, such as Stevens-Johnson syndrome and toxic epidermal necrolysis, are officially documented.

Population-Specific and Safety Restrictions

Dose Dependence: The risk of serious gastrointestinal events is officially stated as being dose-dependent and increases with the length of treatment.
Elderly and Co-morbidities: The elderly population is noted as being at a higher risk for serious gastrointestinal adverse events. Caution is also advised in patients with pre-existing cardiovascular conditions, liver, or kidney impairment.
Contraindications: Use is formally restricted in patients with active gastrointestinal bleeding or ulceration, severe hepatic or renal impairment, or in the third trimester of pregnancy.

Overdose and Emergency Response

Overdose and When to Seek Help

If an overdose of Dofen is suspected, immediate emergency medical attention is required. Serious consequences can occur even if no immediate symptoms are present.

Regulatory documents define the overdose profile primarily through effects on the gastrointestinal and central nervous systems. Official reporting on acute, high-level exposure is associated with a risk of severe systemic complications.

System Affected	Documented Overdose Manifestations
Gastrointestinal	Nausea, vomiting (sometimes bloody), diarrhea, and epigastric pain. Gastrointestinal bleeding, including ulceration, is a serious, documented risk.
Neurological	Lethargy, drowsiness, ringing in the ears (tinnitus), confusion, and, in severe cases, seizures and coma.
Renal/Other	Acute renal failure, hypertension (high blood pressure), and, rarely, respiratory depression.

Circumstances and Required Actions: The majority of acute NSAID overdoses may initially cause only minor, self-limiting symptoms. However, the presence of any severe symptoms, such as gastrointestinal bleeding (black, tarry stools or bloody vomit), loss of consciousness, or breathing difficulty, warrants immediate transport to an emergency department. Treatment involves supportive measures, and in cases of very recent ingestion, procedures like activated charcoal administration may be considered by a healthcare professional.

Therapeutic Uses of Dofen

Dofen (Ibuprofen) is a multi-action medication applied across domains where additional symptomatic support is needed during periods of physical discomfort. It is commonly used across conditions characterized by episodic or fluctuating symptom patterns and may help patients cope more steadily with difficult episodes. It is commonly used to help with fever and manage pain and inflammation caused by several conditions.

The core therapeutic domains include easing mild to moderate pain, managing localized inflammation and swelling, and reducing fever (pyrexia). This makes Dofen relevant in contexts involving acute or disruptive symptom patterns, such as headaches, muscular aches, dental pain, the discomfort of primary dysmenorrhea (menstrual cramps), and pain related to osteoarthritis or certain rheumatoid disorders. The medication supports the patient during difficult episodes by easing distress and contributes to easing day-to-day comfort.

“It is commonly used for conditions that present with disruptive symptom manifestations.”

Easing Mild to Moderate Pain and General Aches

Dofen is primarily applied in scenarios where additional management of discomfort is required for various sources of mild to moderate pain. It helps address symptom clusters such as headaches, muscular aches, dental pain, and the acute, cramping discomfort of primary dysmenorrhea. The medication supports the patient during difficult episodes by easing distress and contributes to easing day-to-day comfort.

Quick Fact: Relevant for Symptoms related to Inflammatory States

Managing Inflammation and Joint-Related Discomfort

The medication is relevant in contexts marked by increased discomfort or tension caused by inflammation and swelling. It is commonly used across conditions presenting with acute episodes, such as osteoarthritis and certain rheumatoid disorders, to ease challenging symptoms like joint pain, stiffness, and localized swelling. This supports patients during episodes of heightened discomfort.

Reducing Fever and Systemic Distress

Dofen is applied during phases when symptoms become more noticeable due to elevated body temperature. It is commonly used for conditions that present with disruptive symptom manifestations like fever (pyrexia) associated with the common cold or flu, and contributes to easing the overall symptom load.

Regulatory References

National Institutes of Health (NIH) MedlinePlus Medical Encyclopedia

Eligibility and Restrictions for Use

Official Eligibility Profile

Dofen (Ibuprofen) is subject to strict eligibility rules defined by regulatory agencies. Use is generally authorized for adults and adolescents, and for children above a specified minimum age or weight (often six months) using specific formulations. Use in older adults requires caution and the lowest effective dose for the shortest duration due to increased risk.

Absolute Non-Eligibility (Contraindications)

Official labeling mandates that Dofen must not be used by patients with specific medical histories or conditions, including:

A history of severe allergic reactions (hypersensitivity) to Ibuprofen, aspirin, or any other Non-Steroidal Anti-Inflammatory Drug (NSAID).
The presence of active or recurrent gastrointestinal (GI) bleeding or peptic ulceration.
Severe heart failure, severe renal impairment (kidney failure), or severe hepatic impairment (liver failure).
Patients in the third trimester of pregnancy (after 28 weeks' gestation).

Conditional or Restricted Use

Use is restricted or conditional for patients with mild to moderate impairment of kidney or liver function. The medicine is also not recommended during the first and second trimesters of pregnancy. However, regulatory guidance indicates that Ibuprofen is generally considered acceptable for use by breastfeeding mothers.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation structures Dofen’s interaction profile primarily around risks associated with co-administration and effects on clearance. Dofen (Ibuprofen) is formally contraindicated for treating peri-operative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery.

Co-administration with other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), including COX-2 selective inhibitors, and high-dose Aspirin (above 75 mg daily) should be avoided due to the increased potential for gastrointestinal adverse events.

Pharmacodynamic and Exposure-Modifying Interactions

Interacting Substance/Class	Official Interaction Statement
Anticoagulants (e.g., Warfarin)	Enhanced effects, increasing bleeding risk.
Antihypertensives (e.g., ACE inhibitors)	May diminish the blood pressure-lowering effect.
Lithium, Methotrexate, Cardiac Glycosides	Potential for increased plasma levels due to reduced clearance.
Diuretics and Immunosuppressants	Increased risk of nephrotoxicity.
Low-Dose Aspirin (Cardioprotective)	Potential for competitive inhibition of anti-platelet effect.

Population-Specific and Substance Constraints: The risk of serious adverse effects, including gastrointestinal bleeding, is noted as higher in elderly patients on concomitant medication. The risk of stomach bleeding is also increased with the concomitant consumption of alcohol.

Mechanism of Action

The mechanism of action for Dofen, based on its active ingredient Ibuprofen, is confined to two primary, interconnected mechanistic domains, focusing on enzyme inhibition to modulate specific physiological responses.

Molecular Targeting: Inhibiting the Cyclooxygenase (COX) Enzyme System

The fundamental mechanism involves the active ingredient, Ibuprofen, acting as a reversible, non-selective inhibitor of the Cyclooxygenase ( COX) enzymes ( COX-1 and COX-2). This interaction primarily affects the eicosanoid synthesis pathway, which is responsible for generating key signaling molecules. By occupying the enzyme's catalytic site, the drug prevents the conversion of arachidonic acid into prostaglandin H2 ( PGH2), thereby initiating the mechanistic cascade that underlies its activity.

Pathway Modulation: Desensitizing Nociception and Central Thermoregulation

The restriction of PGH2 production directly influences systems involved in heightened physiological responses. Reduced synthesis of Prostaglandin E2 ( PGE2) at peripheral sites leads to the desensitization of nociceptor (pain-sensing) neurons, resulting in the modulation of signaling intensity within pain pathways. Simultaneously, the mechanism is applied centrally in the hypothalamus, which results in the interruption of the PGE2 signal that resets the body’s temperature control system, affecting the activity of PGE2 mediators involved in central thermoregulation.

Dosage and Administration Information

How to Use Dofen: Official Administration Guidelines

Administration of Dofen, which contains Ibuprofen, is governed by official prescribing information that details the approved routes, dosage limits, and timing. The overarching principle for all usage is the administration of the lowest effective dose for the shortest duration consistent with the treatment goals.

Administration Scope

Feature	Guideline (Strictly Label-Based)
Route of Administration	Primarily oral, available in tablets, capsules, and suspension. Intravenous (IV) use is an approved alternative reserved for clinical settings when oral intake is not suitable.
Dosing Schedule	For short-term, over-the-counter use, the typical dose is 200 mg to 400 mg, with a maximum self-treatment limit of 1200 mg daily. Prescription use for chronic conditions may involve total daily doses up to 3200 mg, administered in divided doses.
Timing and Frequency	Doses are generally administered every 4 to 6 hours as needed for acute symptoms. For continuous management, the total daily amount is divided and taken three to four times per day.
Contextual Instructions	Oral forms may be taken with food or milk to mitigate the potential for gastric discomfort. Specific tablet forms must be swallowed whole and are not to be crushed or chewed.

Procedural Context

The official guidelines necessitate adhering to a minimum 4-to-6-hour interval between doses. Administration involves selecting the appropriate form, such as shaking the liquid suspension prior to measuring, or ensuring IV solution is infused over the required time period (typically 30 minutes). Dosage adjustments are explicitly advised for certain populations, including older adults and individuals with mild to moderate renal or hepatic impairment, for whom the lowest effective dose should be maintained for the shortest duration.

Recent Clinical Evidence

Research evidence / Overview of Studies for Dofen

Evidence for Use in Mild to Moderate Acute Pain

Research exploring Dofen for conditions such as headache, muscular aches, and dental pain has primarily focused on short-term Randomized Controlled Trials (RCTs) and systematic reviews. These studies were applied in research examining patient-reported experiences related to acute episodes. Researchers examined outcomes related to outcomes describing episodic or acute changes by measuring shifts in pain intensity over time and monitoring the need for rescue analgesia.

The study populations included were typically Adults and Adolescents presenting with acute pain. Studies conducted during periods of increased symptom activity reported observations related to changes measured during the study period compared to placebo. It remains uncertain how these short-term findings translate to patterns of repeated use over extended periods.

Evidence for Managing Fever and Primary Dysmenorrhea

Dofen was evaluated in studies examining outcomes related to pyrexia (elevated body temperature). This research primarily used RCTs comparing the medication to inactive substances or active comparators. Outcomes related to systemic or functional imbalance were monitored, specifically looking at changes in body temperature and the time interval over which these changes were observed.

Separately, the medication was also studied for conditions characterized by fluctuating or episodic manifestations, specifically primary dysmenorrhea (menstrual cramps). Studies observed responses over defined time intervals, monitoring patient-reported outcomes describing perceived discomfort and the need for rescue analgesia.

Evidence for Outcomes in Inflammatory Disorders

The research examined outcomes related to conditions marked by functional limitations, such as osteoarthritis, which has been explored through both medium-term RCTs and longer Observational Studies (OSs). This research focused on functional scales and patient-reported changes in joint stiffness and daily functioning in populations like Older Adults.

What Research Gaps and Uncertainties Remain

While the short-term research for acute pain and fever is extensive, there is limited information for long-term outcomes related to intermittent use over many years. Follow-up durations were limited in many acute trials, and the study findings reflect the specific populations and conditions under which the research was conducted, meaning subgroup findings are uncertain for individuals outside the main study parameters. Comparative evidence against some newer therapeutic classes is limited.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about Dofen (FAQ)

Q: How quickly can I expect Dofen to start working?

Official product information indicates that Dofen (Ibuprofen) is absorbed quickly after administration. Pain relief effects are generally observed starting within 20 to 30 minutes, with the most noticeable effects typically occurring within one to two hours.

Q: Does Dofen stay in your system for a long time?

No. Official documents on how the drug is processed in the body, known as pharmacokinetics, report that Dofen (Ibuprofen) has a short elimination half-life, usually around 1.8 to 2 hours in healthy adults. This indicates that the drug is substantially cleared from the system approximately 10 to 12 hours after a dose.

Q: Can Dofen be taken at the same time as common vitamins?

Regulatory warnings focus on specific drug-drug or drug-alcohol interactions. There are generally no specific warnings in official product labeling that prohibit taking Dofen (Ibuprofen) with common over-the-counter vitamin or mineral supplements.

Q: Is it possible to become dependent on Dofen?

Dofen (Ibuprofen) is not classified as a controlled substance by regulatory authorities. Regulatory classification indicates it is not typically associated with physical dependence or addiction.

Q: Are there specific foods or drinks that should be avoided when taking Dofen?

Official documentation includes a clear warning that the risk of serious stomach bleeding is increased with the concomitant consumption of alcohol. The official documentation raises awareness of this risk when considering concurrent use. No specific foods or non-alcoholic drinks are listed with similar official warnings.

Q: What kind of studies support the use of Dofen?

The approved uses of Dofen (Ibuprofen) are supported by extensive research. This includes Randomized Controlled Trials (RCTs) and systematic reviews, which have examined outcomes for pain, fever, and inflammatory conditions in various populations.

Q: Why is Dofen sometimes prescribed 'off-label' (clarification of the concept)?

The term 'off-label' is a descriptive concept that clarifies when a medicine is described as being used for a medical condition, population, or in a manner that is not specifically included in the drug's official, government-approved regulatory labeling.

Q: How soon after stopping Dofen can I take [interacting substance]? (Informational query)

Official pharmacokinetic data indicates that Dofen (Ibuprofen) has a short half-life. The drug is largely eliminated from the body within 10 to 12 hours after the last dose. This timeframe is based on the drug's short half-life, which describes when the drug concentration is significantly reduced.

Q: What is the general timeline for seeing the full benefits of Dofen?

For acute pain, the effects are rapid, often beginning within 30 minutes. For continuous management of chronic conditions, a full response is often described in research as being observed within two weeks of initiating therapy.

Q: Are there groups of people where Dofen has limited study data?

While short-term research for acute uses is extensive, official documentation notes there is limited information regarding long-term outcomes related to intermittent use over extended periods.

Q: Are there different brand names for the same Dofen component?

Yes. The active ingredient in Dofen is Ibuprofen. Ibuprofen is an ingredient available under numerous different brand names and also as a generic product across the market.

Q: What does the term 'pharmacodynamics' mean in relation to Dofen?

The term pharmacodynamics is used to describe how Dofen (Ibuprofen) actually affects the body. Specifically, Dofen achieves its effects by reversibly inhibiting the Cyclooxygenase (COX) enzyme system, which reduces the production of molecules that cause pain and inflammation.

Q: How are the clinical trials for Dofen typically structured?

Clinical evidence for Dofen (Ibuprofen) is based on studies that include short-term Randomized Controlled Trials (RCTs) for acute conditions like pain and fever, and longer Observational Studies (OSs) for inflammatory disorders.

Q: Is Dofen a controlled substance?

No, Dofen (Ibuprofen) is an over-the-counter and prescription medicine. It is not classified as a controlled substance by regulatory authorities in charge of tracking drugs with potential for abuse or dependence.

Q: What is the typical half-life of Dofen?

The typical elimination half-life of Dofen (Ibuprofen)—the time it takes for half of the drug to be eliminated from the body—is reported in official documents to be approximately 1.8 to 2 hours in healthy adults.

Q: Does Dofen contain lactose or gluten?

The inactive ingredients can vary based on the specific tablet or capsule form and the manufacturer. Many Dofen (Ibuprofen) products are officially listed as containing lactose as an inactive component. The risk of gluten content is typically low, but specific product labeling should be consulted for complete ingredient disclosure.

Q: What is the expiration period for Dofen tablets?

The expiration period is not a general statement in the labeling but is determined by the manufacturer based on official stability requirements. The specific expiration date is always printed on the packaging and should be strictly observed.

Q: Is Dofen similar to other medicines for [related condition]?

Dofen is classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID). It shares a common mechanism of action (inhibiting the COX enzyme system) with other medicines in this class that are used to address pain, fever, and inflammation.

Q: Can Dofen cause drowsiness during the day?

Yes, official regulatory documents list drowsiness and dizziness as common adverse reactions associated with the use of Dofen (Ibuprofen). This effect is noted in the official documentation.

Q: What happens if Dofen is taken with alcohol?

Official warnings state that taking Dofen (Ibuprofen) with alcohol increases the risk of serious gastrointestinal bleeding. The official documentation emphasizes this risk when use is concurrent.

Q: Is Dofen considered a drug with a high risk of drug-drug interactions?

Regulatory documents list numerous and medically significant interactions with various classes of medicines, including blood thinners, blood pressure medications, and water pills. This information indicates that Dofen has a complex interaction profile as defined by regulatory documents.

Q: Is it common for Dofen to cause stomach upset?

Yes. Gastrointestinal reactions such as abdominal pain, nausea, diarrhea, and heartburn are listed in regulatory documents as common adverse reactions associated with Dofen use. This indicates that these effects are described as common in the official adverse reaction data.

Q: What are the rules about taking Dofen with food?

Official administration guidelines note that oral forms of Dofen (Ibuprofen) may be taken with food or milk. This practice is noted in the official administration guidelines to help mitigate the potential for gastric discomfort.

Q: Can Dofen be crushed or chewed?

Official administration guidelines specify that non-chewable tablet forms are to be swallowed whole and are not to be crushed or chewed. There are, however, specific liquid suspension or chewable forms that are designed to be administered differently.

How should Dofen be stored and disposed of?

How to Store and Dispose of Dofen

Official labeling requires Dofen tablets to be stored at a temperature below 30°C (86°F) and protected from direct light and moisture. The product must not be frozen. To maintain stability until the expiration date, the medicine must remain in its original container, which should be kept tightly closed when not in use.

Child Safety and Disposal

To prevent accidental ingestion, Dofen must be stored out of the sight and reach of children. For unused or expired medicine, disposal must follow local regulations. Authorities often recommend utilizing a drug take-back program or mail-back envelope for safe disposal. If discarded in household trash, the product should be mixed with an unappealing substance, but pills should not be crushed.

Dofen